Skip to main content

Immunocore Holdings plc 10-Q for FY2026 Q3

Immunocore Holdings plc (IMCR)

10-Q 2026-11-06 For: 2026-09-30
View Original
Added on November 06, 2026

About this 10-Q

Immunocore Holdings plc filed this 10-Q on November 6, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Immunocore Holdings plc generated $324.8 million in KIMMTRAK revenue for the nine months ended September 30, 2026, up 9.9%, while cash reached $512.2 million. Existing liquidity and anticipated KIMMTRAK revenue should fund operations for at least twelve months. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$102.22M
down 1.4% from $103.69M a year earlier
Net loss
$14.22M
compared with a net loss of $177K a year earlier
Diluted EPS
-$0.28
compared with $0.00 a year earlier